Latanoprost
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Latanoprost and local guidelines before prescribing.
Mechanism
Prostaglandin F2-alpha analogue increasing uveoscleral outflow.
Uses
Open-angle glaucoma and ocular hypertension.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Eye redness, iris and eyelash changes, periocular pigmentation, stinging.
Interactions
Few; other prostaglandin analogues avoided.
Contraindications and cautions
Active uveitis, macular oedema
Monitoring
Intraocular pressure
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Not applicable
Special advice
Once daily in the evening; warn about permanent iris colour change; remove contact lenses before use.
More from the textbook: uses, cautions and other points
- Prostaglandin analogues (latanoprost, bimatoprost, travoprost) — once daily at night; first-line drops | Increase uveoscleral outflow | Darkening of the iris (permanent, brown), eyelash growth , periocular skin darkening, periorbital fat loss, red eye; caution in uveitis and after complicated cataract surgery (macular oedema)
Ophthalmology: Anatomy Physiology and Pharmacology - Prostaglandin analogues (latanoprost, bimatoprost, travoprost) - first-line drops , once at night. Increase outflow. Side effects: darker iris colour , longer eyelashes, red eyes, darkened eyelid skin.
Ophthalmology Basics Cataract Glaucoma - Latanoprost (prostaglandin analogue) | First-line glaucoma drop, once at night. Darker iris, long lashes, red eye.
Ophthalmology Basics Cataract Glaucoma
Where it is discussed in the book
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology Basics Cataract Glaucoma (2 mentions)